Finanzwire
COMMUNIQUÉ DE PRESSE

par DKSH Management Ltd. (isin : CH0126673539)

DKSH Technology Strengthens Its Business in Australia and New Zealand With the Acquisition of Bio-Strategy

DKSH Management Ltd. / Key word(s): Takeover
DKSH Technology Strengthens Its Business in Australia and New Zealand With the Acquisition of Bio-Strategy

02.11.2023 / 07:00 CET/CEST

Media release

DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth.

<div> <p><span>Zurich, Switzerland, November 2, 2023 – DKSH has announced today that it signed an agreement for the acquisition of Bio-Strategy, the largest independent distributor of scientific instruments in Australia and New Zealand, focusing primarily on life sciences, medical & healthcare and environment & agriculture segments. </span></p> <p><span> </span></p> <p><span>Established 2003 and based in Melbourne, Bio-Strategy generates net sales of more than CHF 40 million</span><span style="vertical-align: super;">1</span><span> at good profitability. With a team of over 100 people, the company serves renowned blue chip clients and distributes products and services to around 1,200 customers. DKSH acquires 100% of the business and its management team and employees will join DKSH’s Business Unit Technology. </span></p> <p><span> </span></p> <p><span>Hanno Elbraechter, Head Business Unit Technology at DKSH, commented: “I am delighted with the acquisition of Bio-Strategy as an important addition to DKSH. The specific industry and application knowledge of the company will help us to solidify our position in two of Asia Pacific’s key markets. While complementing both DKSH Technology’s product portfolio and regional presence, the acquired expertise will enable us to create added value for our clients and customers.”</span></p> <p><span> </span></p> <p><span>John Chesterfield, CEO of Bio-Strategy, said: “We are pleased about the combination with DKSH, one of Asia’s leading technology distribution players, marking the next big step in our 20-year journey. In addition to a wider regional reach and an enlarged product and service portfolio, our clients, customers, employees, and business partners will benefit from various synergies. We are excited about our shared future, to leverage our common expertise and to continue successfully serving our stakeholders.”</span></p> <p><span> </span></p> <p><span>The closing of the transaction is expected during the fourth quarter of 2023 and is subject to certain conditions.</span></p> <p><span> </span></p> <p><span style="vertical-align: super; font-style: italic;">1 </span><span style="font-style: italic;">Exchange rate 1 Swiss Franc / 1.88 NZD</span></p> </div> </div><div markup="contact"><p><span><span style="font-weight: bold;">For further information, please contact:</span></span></p> <p><span> </span></p> <p><span><span style="font-weight: bold;">DKSH Holding Ltd.</span></span></p> <p><span> </span></p> <p><span>Till Leisner</span></p> <p><span>Head, Group Investor & Media Relations, Sustainability</span></p> <p><span>Phone +41 44 386 7315<span style="display: inline-block; width: 21.94pt;"> </span></span></p> <p><span><a href="mailto:till.leisner@dksh.com" style="text-decoration: underline;">till.leisner@dksh.com</a></span></p> <p> </p> <p><span><span>Melanie Grüter</span></span></p> <p><span><span lang="EN-US">Manager Group Media Relations</span></span></p> <p><span><span lang="FR">Phone +41 44 386 7211</span></span></p> <p><span><a href="mailto:melanie.grueter@dksh.com" style="text-decoration: underline;">melanie.grueter@dksh.com</a></span></p> <p> </p> </div></div> <br/><hr/><p> End of Media Release<br/></p> <hr/></td> </tr></table><table cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" nowrap="nowrap">Language:</td> <td align="left" valign="top">English</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">Company:</td> <td align="left" valign="top">DKSH Management Ltd.</td> </tr><tr><td align="left" valign="top"/> <td align="left" valign="top">Wiesenstrasse 8</td> </tr><tr><td align="left" valign="top"/> <td align="left" valign="top">8008 Zurich</td> </tr><tr><td align="left" valign="top"/> <td align="left" valign="top">Switzerland</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">Phone:</td> <td align="left" valign="top">044 386 72 72</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">E-mail:</td> <td align="left" valign="top">media@dksh.com</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">Internet:</td> <td align="left" valign="top">www.dksh.com</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">ISIN:</td> <td align="left" valign="top">CH0126673539</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">Valor:</td> <td align="left" valign="top">12667353</td> </tr><tr><td align="left" valign="top">Listed:</td> <td align="left" valign="top">SIX Swiss Exchange</td> </tr><tr><td align="left" valign="top" nowrap="nowrap">EQS News ID:</td> <td align="left" valign="top">1763077</td> </tr></table><br/><table border="0" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" colspan="2"/> </tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" colspan="2"> </td> </tr><tr><td align="left" valign="top">End of News</td> <td align="left" valign="top">EQS News Service</td> </tr></table><table border="0" width="600" cellpadding="0" cellspacing="0"><tr><td> <hr/></td> </tr></table><p> 1763077  02.11.2023 CET/CEST </p> <img src="https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1763077&application_name=news&site_id=symex" alt="fncls.ssp?fn=show_t_gif&application_id=1763077&application_name=news&site_id=symex" width="0" height="0" border="0"/>
Voir toutes les actualités de DKSH Management Ltd.